Mode
Text Size
Log in / Sign up

Explainable AI methods may address black-box limitations in clinical microbiology and infectious diseasesReview explores how explainable AI could help in infectious disease medicine

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider AI's black-box limitation when evaluating its clinical microbiology applications.

This narrative review discusses advancements in Explainable AI (XAI) methods for clinical applications in microbiology, infectious diseases, and public health. The review does not report specific study designs, populations, sample sizes, or clinical settings. It focuses on the conceptual challenge of AI opacity in clinical integration.

No specific interventions, comparators, or clinical outcomes are reported. The review identifies the 'black-box' aspect of AI as a key barrier to clinical adoption. No numerical data, safety information, or tolerability findings are presented.

Key limitations include the narrative review format, which may not systematically assess evidence. No funding sources or conflicts of interest are reported. The practice relevance is not specified, and the review provides conceptual discussion rather than clinical validation of XAI methods.

A recent review paper looked at the idea of using explainable artificial intelligence (XAI) in areas like clinical microbiology, infectious diseases, and public health. XAI refers to AI systems designed to show how they reach their conclusions, rather than acting as a 'black box.' The authors explored the potential advancements these methods could bring to medical practice.

The review did not involve a specific study with patients or report on new experimental results. Instead, it discussed the general concept and challenges. A key point made is that the 'black-box' nature of many current AI systems—where it's unclear how they make decisions—is a major barrier to using them safely in clinical care.

Because this is a narrative review and not original research, it presents ideas and discussions rather than proven facts. Readers should understand that the paper is exploring possibilities, not reporting on tested, ready-to-use tools. The main takeaway is that making AI more understandable is an important goal for its future in medicine, but much more research and testing is needed before such systems could be reliably used in patient care.

What this means for you:
Explainable AI is being explored for medicine, but it remains an early concept, not a proven clinical tool.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Antimicrobial resistance and emerging infectious diseases remain significant challenges for global health, driving a need for advanced technological solutions. Artificial Intelligence (AI) expanded opportunities in clinical microbiology, infectious diseases, and public health by harnessing vast, structured datasets. Despite impressive analytical capabilities, the clinical integration of AI-based applications is hindered by its opacity. The “black-box” aspect undermines adoption into healthcare workflows. Explainable AI (XAI) methods, including intrinsically interpretable models and post-hoc interpretability tools, such as SHAP, LIME, and Grad-CAM, can address these transparency challenges. This narrative review is intended to be a primer for the interested clinician. It systematically evaluates recent advancements in XAI in the context of clinical applications for clinical microbiology, infectious diseases, and public health. We further discuss the ethical and regulatory landscape shaping AI adoption, including the critical role of open, quality-controlled data, robust performance metrics, and clear interpretability to ensure safe and effective clinical implementation. Lastly, we propose future directions, emphasizing interdisciplinary collaboration, international data-sharing initiatives, and tailored AI literacy training to facilitate trustworthy, equitable, and impactful use of AI in clinical microbiology and infectious diseases.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.